Consistently in patients and rats with type 2 diabetic nephropathy, the miR-33 expression has been associated with renal inflammation and fibrosis via activating the NF-κB/TGF-β pathway (5, 44). This evidence concerns the gene NFKB1 and type 2 diabetes nephropathy.